A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group phase III randomized trial
S. J. Lauer, J. J. Shuster, D. H. Mahoney, N. Winick, S. Toledano, L. Munoz, G. Kiefer, J. D. Pullen, C. P. Steuber, B. M. Camitta
Dive into the research topics of 'A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group phase III randomized trial'. Together they form a unique fingerprint.